In heart failure, treatment with an angiotensin receptor–neprilysin inhibitor, elevating natriuretic peptide levels, improved heart failure with reduced ejection fraction (HFrEF)6 and, in women, also heart failure with preserved ejection fraction (HFpEF).7 This evidence concerns the gene MME and heart failure.